Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 15, 2 Issues, 2017

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents

Anti-Infective Agents, 7(3): 169-179.

Author(s): Jean-Yves Winum, Stephan Kohler, Andrea Scozzafava, Jean-Louis Montero and Claudiu T Supuran.

Affiliation: Institut des Biomolecules Max Mousseron (IBMM) UMR 5247 CNRS-UM1-UM2 Batiment de Recherche Max Mousseron, Ecole Nationale Superieure de Chimie de Montpellier,8 rue de l'Ecole Normale, 34296 Montpellier Cedex, France.


Metalloenzymes are widespread proteins, ubiquitous in all life kingdoms, being involved in various biosynthetic processes. Some of them have been extensively studied in mammals and there are excellent examples for mechanism- based inhibitor design. α-Carbonic anhydrases (CAs), matrix metalloproteinases (MMP), or angiotensin-converting enzyme (ACE), among others, are clinically exploited targets in the treatment or prevention of a variety of diseases such as congestive heart failure, hypertension, glaucoma, epilepsy, and cancer among others. The potential of metalloenzymes as anti-bacterial targets has been taken in consideration only recently. As approximately 3-5% of the bacterial genome encodes metalloenzymes, prokaryotic metalloenzymes such as Peptide Deformylase (PDF), α- β- and γ-CAs and Histidinol Dehydrogenase (HDH), have emerged as new promising antibacterial targets in the search of novel anti-infective agents that lack cross-resistance to existing drugs. Several of these enzymes are required for growth and virulence in several pathogenic species. Their inhibition therefore constitutes an important new approach which has been already successfully applied to the discovery of antibacterial agents active in vivo. This review illustrates and describes the progress which has been made in the design and the discovery of selective inhibitors of bacterial metalloenzymes as new antibacterial agents.


Metalloenzymes inhibitors, antibacterial, peptide deformylase, carbonic anhydrase, histidinol dehydrogenase.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 7
Issue Number: 3
First Page: 169
Last Page: 179
Page Count: 11
DOI: 10.2174/187152108784911232
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science